PEGPH20

Date Title

Hingorani S.R., et al. Phase 1b Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer; Clinical Cancer Research; 2016. 01/26/16

Shepard H.M. Breaching the Castle Walls: Hyaluronan-Depletion as a Therapeutic Approach to Cancer Therapy; Frontiers in Oncology; 2015. 09/28/15

Manuel E.R., et al. Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumor; Cancer Immunol Res; 2015. 07/01/15

Whatcott C.J., et al. Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer; Clinical Cancer Research; 2015. 02/18/15

Singha N.C., et al. Tumor-Associated Hyaluronan Limits Efficacy of Monoclonal Antibody Therapy; Molecular Cancer Therapeutics; 2015. 12/15/14

Jacobetz M.A., et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer; Gut; 2012. 03/30/12

Provenzano P., et al. Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma; Cancer Cell; 2013. 03/20/12

Thompson C.B., et al. Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models; Molecular Cancer Therapeutics; 2010. 10/26/10

Companion Diagnostic (CDx)

Date Title

Jadin L., et al. Hyaluronan expression in primary and secondary brain tumors; Annals of Translational Medicine; 2015. 04/03/15

Jadin L., et al. Characterization of a Novel Recombinant Hyaluronan Binding Protein for Tissue Hyaluronan Detection; Journal of Histochemistry and Cytochemistry; 2014. 06/02/14

Useful Links

Copyright © 2015-2017 . Halozyme, Inc. All rights reserved. All trademarks belong to their respective owners.

Powered By Q4 Inc. 5.4.1.6

Notice

You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.

Ok